U.S., May 24 -- ClinicalTrials.gov registry received information related to the study (NCT06987474) titled 'Capella Scientia Development Study' on May 16.
Brief Summary: This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
Study Start Date: June, 2025
Study Type: OBSERVATIONAL
Condition:
Cataract
Intervention:
DEVICE: Unity DX and SMARTCataract DX (SCDX) Biometer
Unity DX is a CE-marked, noninvasive, noncontact instrument that generates a 3D model of the eye using hyper parallel optical coherence tomography (HP OCT), aberrometry, and topography. The current version of SCDX software will be used in this study.
DEVICE: IOLMaster 700 Biometer
The IOLMaster 700 Biometer is a CE-mark...